M. G. Sevag
-
- Antibiotic Resistance in Bacteria 2
-
- Bacterial Genetics and Biotechnology 6
-
- Bacteriophages and microbial interactions 4
-
- Pharmaceutical and Antibiotic Environmental Impacts 4
-
- Synthesis and Reactivity of Heterocycles 3
-
- Pneumonia and Respiratory Infections 2
-
- Probiotics and Fermented Foods 2
-
- Biotin and Related Studies 2
- Co-authors
- Hillel S. LevinsonMasanosuke YoshikawaMartin ForbesW. T. DrabbleGerhard HaasTakeshi YokotaRichard C. StewartK. Ishii
- Partner nations
- United States
In The Last Decade
M. G. Sevag
31 papers receiving 243 citations
Peers
Comparison fields: 5 of 64
- Molecular Medicine 24
- Biotechnology 28
- Applied Microbiology and Biotechnology 5
- Endocrinology 12
- Pharmaceutical Science 14
Countries citing papers authored by M. G. Sevag
This map shows the geographic impact of M. G. Sevag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Sevag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Sevag more than expected).
Fields of papers citing papers by M. G. Sevag
This network shows the impact of papers produced by M. G. Sevag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Sevag. The network helps show where M. G. Sevag may publish in the future.
Co-authorship network
The 10 scholars most cited alongside M. G. Sevag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1967 | 24 | |
| 2 | 1964 | 20 | |
| 3 | 1962 | 12 | |
| 4 | 1960 | 4 | |
| 5 | 1960 | 5 | |
| 6 | 1958 | 5 | |
| 7 | 1958 | 2 | |
| 8 | Inhibition by cycloserine of the synthesis of 5-amino-4-imidazolecarboxamide by Escherichia coli. | 1956 | 1 |
| 9 | 1956 | 2 | |
| 10 | 1955 | 1 | |
| 11 | Phosphatase-antiphosphatase reaction; competition between the specific substrate and antiphosphatase for phosphatase. | 1954 | 12 |
| 12 | 1954 | 13 | |
| 13 | 1953 | 57 | |
| 14 | 1953 | 9 | |
| 15 | 1953 | 1 | |
| 16 | 1952 | 14 | |
| 17 | 1952 | 2 | |
| 18 | 1951 | 5 | |
| 19 | 1951 | 1 | |
| 20 | 1951 | 7 |
About M. G. Sevag
M. G. Sevag is a scholar working on Pollution, Molecular Medicine and Biotechnology, having authored 31 papers that have together received 279 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (6 papers), Bacteriophages and microbial interactions (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Synthesis and Reactivity of Heterocycles (3 papers), Pneumonia and Respiratory Infections (2 papers), Probiotics and Fermented Foods (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Biotin and Related Studies (2 papers). The work is most often cited by research in Molecular Medicine (24 citations), Biotechnology (28 citations) and Applied Microbiology and Biotechnology (5 citations). M. G. Sevag has collaborated with scholars based in United States. Frequent co-authors include Hillel S. Levinson, Masanosuke Yoshikawa, Martin Forbes, W. T. Drabble, Gerhard Haas, Takeshi Yokota, Richard C. Stewart, K. Ishii, Irving J. Slotnick and Akira Yoshida. Their work appears in journals such as Nature, The Journal of Immunology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.